Home >
Medicine Info >
Meganeuron PG Capsule
Loading interface...

Meganeuron PG Capsule

Manufactured byARISTO PHARMACEUTICALS PVT LTD
ContainsBenfotiamine (7.5 mg) + (0.75 mg) + Methylcobalamin (750 mcg) + Pyridoxine (1.5 mg) + Pregabalin (75 mg)
Description
Meganeuron PG Capsule is a combination medicine that consists of Benfotiamine, Folic acid, Methylcobalamin, Pyridoxine and Pregabalin. It is used to treat neuropathic pain (pain due to nerve damage). This medicine protects the nerves from getting damaged and regenerates the damaged nerves. Meganeuron PG Capsule has some common side effects like diarrhoea, nausea and vomiting. It may also cause dizziness in some people. Avoid driving vehicles or operating machines if you feel dizzy after taking this medicine. If any of these side effects do not resolve with time or worsen, consult your doctor. Avoid taking this medicine if you are allergic to it. Meganeuron PG Capsule can be taken with or without food. To maintain constant levels of this medicine, take it at the same time every day. Take this medicine in the dose and for the duration as prescribed by your doctor. Do not stop taking this medicine without consulting your doctor. If stopped abruptly, you might experience withdrawal symptoms like anxiety, fatigue, sweating, vomiting, depression, seizures, and hallucinations. Meganeuron PG Capsule is not recommended for use in children less than 18 years of age. Inform your doctor if you have kidney or liver problems before taking it as this medicine may worsen your condition. Consult your doctor if you are pregnant, or are breastfeeding before taking this medicine. Meganeuron PG Capsule may cause drowsiness. Be careful when you rise from a sitting or lying position, as this medicine may cause dizziness. Do not consume alcohol while using this medicine as it can lead to excessive drowsiness.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Meganeuron PG Capsule

  • Difficulty in breathing
  • Chest tightness
  • Chills
  • Unusual tiredness and weakness
  • Blurred or double vision
  • Dizziness
  • Dry mouth
  • Headache
  • Loss of coordination
  • Slurred speech
  • Trouble sleeping
  • Loss of bladder control
  • Restlessness
  • Cough
  • Difficulty in swallowing
  • Itching and skin rash
  • Weight gain
  • Clumsiness
  • Numbness of hands or feet
  • Unsteady walk
  • Weakness and general discomfort
  • Stomach discomfort and pain
  • Nausea and Vomiting

Uses of Meganeuron PG Capsule

What is it prescribed for?

  • Diabetic Neuropathy
  • Postherpetic Neuralgia
  • Wernicke Encephalopathy
  • Inflammatory skin conditions
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time taken by Meganeuron PG Capsule to show its effect is 1 hour after taking it.
  • How long do the effects of this medicine last?
    The average time for which Meganeuron PG Capsule remains effective is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Do not consume alcohol while taking Meganeuron PG Capsule as it may increase the risk of drowsiness, dizziness, and difficulty in concentrating.
  • Is this a habit forming medicine?
    Meganeuron PG Capsule has no habit-forming tendency.
  • Can this medicine be taken during pregnancy?
    Meganeuron PG Capsuleis not recommended for use in pregnancy as it may harm your foetus. Consult your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Meganeuron PG Capsule is not recommended for use in breastfeeding as it may pass into breastmilk and harm your baby. Consult your doctor before taking this medicine.

Allergy

Avoid taking Meganeuron PG Capsule if you are allergic to it. Seek medical attention if you experience any undesirable effects such as skin rash, hives (rash that stings), swelling (face, lips, tongue), etc.

Leber Hereditary Optic Neuropathy

Leber Hereditary Optic Neuropathy (LHON) is a rare genetic disorder, characterized by pain in the eye and surrounding area with loss of vision (sometimes blindness) caused by eye nerve (optic nerve) damage. Meganeuron PG Capsule is not recommended for use if have this genetic eye disorder as it can cause atrophy (decrease in the size of nerves) that may worsen your condition.
Warnings for special population

Pregnancy

Meganeuron PG Capsuleis not recommended for use in pregnancy as it may harm your foetus. Consult your doctor before taking this medicine.

Breast-feeding

Meganeuron PG Capsule is not recommended for use in breastfeeding as it may pass into breastmilk and harm your baby. Consult your doctor before taking this medicine.
General warnings

Kidney diseases

Meganeuron PG Capsule should be used with extreme caution if you have an impaired kidney function. Your doctor will advise kidney tests while taking this medicine. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

Suicidal tendencies

Meganeuron PG Capsule may cause suicidal ideation (suicidal thoughts). Caution should be maintained while using this medicine if you have any psychological condition. Your doctor may monitor you closely for any mood and behavioural changes. Your doctor may prescribe a suitable alternative based on your condition.

Driving or operating machines

Avoid performing activities that need high mental alertness like driving vehicles or operating machines after taking Meganeuron PG Capsule as it may increase the risk of drowsiness, dizziness, and difficulty in concentrating.

Withdrawal symptoms

Use of Meganeuron PG Capsule should not be stopped abruptly. The risk of withdrawal symptoms is significantly high if it is discontinued suddenly. Complete the treatment with this medicine as prescribed by your doctor.

Heart block

Meganeuron PG Capsule may cause heart rhythm abnormalities which could result in a blockage and associated complications. It should be used with caution if you have any condition related to the heart and blood vessels. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative as needed, based on your clinical condition.

Use in children

Meganeuron PG Capsule is not recommended for use in children under 18 years of age due to the lack of safety and efficacy data.

Use in elderly

Meganeuron PG Capsule should be used with caution in elderly. Appropriate dose adjustments or replacement with a suitable alternative may be required in elderly people.

Gastrointestinal surgery

Meganeuron PG Capsule should be used with caution if you have had recent surgery of the stomach or intestines, as they may have reduced absorption of this medicine.

Missed Dose

Take the missed dose of Meganeuron PG Capsule as soon as you remember. If it is time for your next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Never take more than the prescribed dose. Seek emergency medical treatment if you suspect that you might have taken an overdose of Meganeuron PG Capsule .
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Do not consume alcohol while taking Meganeuron PG Capsule as it may increase the risk of drowsiness, dizziness, and difficulty in concentrating.
Interaction with Medicine

Chloramphenicol

Lorazepam

Omeprazole

Ranitidine

Levodopa

Phenobarbital

Hydralazine

Oral Antidiabetic Agents

Disease interactions

Angioedema

Meganeuron PG Capsule should be used with caution if you have angioedema (painless swelling under the skin, triggered by an allergy to animal dander, pollen, drugs, venom, food or medication) since it may worsen your condition. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative as needed, based on your clinical condition and therapeutic response.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Meganeuron PG Capsule with or without food as instructed by your doctor. Do not take in larger or smaller amounts than prescribed. Ensure that the course of treatment is completed and do not stop without consulting your doctor since this may cause severe withdrawal symptoms. Consult the doctor if you develop any unusual mood changes, depression, or suicidal thoughts while taking this medicine. Keep the medicine away from the reach of children and pets. Ensure that the unused medicine is disposed of properly.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
Meganeuron PG Capsule is a combination of Benfotiamine, Folic acid, Methylcobalamin, Pyridoxine and Pregabalin. Benfotiamine and folic acid provide essential nutrients to the nerves for their proper functioning. Methylcobalamin and pyridoxine help in the formation of the myelin sheath (protective outer coving of the nerve) and helps in rejuvenating damaged nerves. Pregabalin reduces pain by modulating chemical messengers in the nerve cells. Together they relieve neuropathic pain.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Oral nutritional supplements

Schedule

Schedule H

Dailymed.nlm.nih.gov. 2021. DailyMed - FOLIC ACID tablet. [online] Available at: [Accessed 5 July 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8fe09f0-b32b-43e3-8de7-ed38593b33b4

Dailymed.nlm.nih.gov. 2021. DailyMed - LYRICA- pregabalin 75mg capsule. [online] Available at: [Accessed 5 July 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afc8c76e-9b21-7ddb-e053-2a95a90ad736

Drugs, H., 2021. Pyridoxine: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 5 July 2021].

https://medlineplus.gov/druginfo/meds/a682587.html

Ravimiregister.ee. 2021. [online] Available at: [Accessed 5 July 2021].

https://www.ravimiregister.ee/Data/PIL_ENG/PIL_14350_ENG.pdf

2021. [online] Available at: [Accessed 5 July 2021].

https://www.npra.gov.my/images/reg-and-noti/PI/non-poison/Mecobalamin-Template-oral-Website.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Feb 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.